Seres Therapeutics (MCRB) Cash & Equivalents (2014 - 2026)
Seres Therapeutics (MCRB) reported Cash & Equivalents of $15.59 million for Q2 2026, down 65.6% from $45.38 million a year earlier and down 47.7% from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) Cash & Equivalents (2014 - 2026) Analysis & Trends
At the end of FY2025, Seres Therapeutics posted Cash & Equivalents of $45.77 million, up 48.6% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -17.0% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $30.79 million in FY2024 (-75.9%), $127.97 million in FY2023 (-21.5%), $163.03 million in FY2022 (-9.4%) and $180 million in FY2021 (+55.1%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Equivalents since Q3 2014.
- Year over year, Cash & Equivalents gained in 1 of the last eight quarters, with an average decline of 39.4%.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2022 (growth of 130.1%); the low point was Q4 2024 (a decline of 75.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $29.83 million (Q1 2026), $45.77 million (Q4 2025) and $47.64 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,149.24 Bn | 1,117.83 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.01 Bn | 555.87 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 500.63 Bn | 473.74 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 357.88 Bn | 312.26 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 301.63 Bn | 265.62 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.02 Bn | 238.70 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 238.20 Bn | 193.60 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.85 Bn | 169.05 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.94 Bn | 118.58 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Seres Therapeutics | 20.67 Mn | -118.16 Mn | - | 15.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.59 Mn |
| Mar 31, 2026 | 29.83 Mn |
| Dec 31, 2025 | 45.77 Mn |
| Sep 30, 2025 | 47.64 Mn |
| Jun 30, 2025 | 45.38 Mn |
| Mar 31, 2025 | 58.85 Mn |
| Dec 31, 2024 | 30.79 Mn |
| Sep 30, 2024 | 66.82 Mn |
| Jun 30, 2024 | 71.23 Mn |
| Mar 31, 2024 | 111.18 Mn |
| Dec 31, 2023 | 127.97 Mn |
| Sep 30, 2023 | 169.91 Mn |
| Jun 30, 2023 | 229.52 Mn |
| Mar 31, 2023 | 94.84 Mn |
| Dec 31, 2022 | 163.03 Mn |
| Sep 30, 2022 | 205.40 Mn |
| Jun 30, 2022 | 126.82 Mn |
| Mar 31, 2022 | 153.19 Mn |
| Dec 31, 2021 | 180.00 Mn |
| Sep 30, 2021 | 227.46 Mn |
API Access
Seres Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();